Danaher Targets Faster Growth With Acquisitions, AI and a Diagnostics Push
Danaher (NYSE:DHR) is focusing on commercial execution, innovation and acquisitions as it seeks faster core growth and market-share gains, company leader Julie said during a discussion with Tycho Peterson of the Life Science team. Julie, who was identified only by her first name in the transcript,
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo